HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bala Attili Selected Research

Phosphotransferases (Kinase)

1/2021Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bala Attili Research Topics

Disease

5Neoplasms (Cancer)
03/2023 - 12/2020
2Neuroinflammatory Diseases
01/2020 - 01/2019
1Neoplasm Metastasis (Metastasis)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1medullary Thyroid cancer
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Melanoma (Melanoma, Malignant)
01/2019

Drug/Important Bio-Agent (IBA)

2PhosphatidylserinesIBA
03/2023 - 12/2020
2Carrier Proteins (Binding Protein)IBA
03/2023 - 12/2020
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2021
12- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanolIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Radioisotopes (Radionuclides)IBA
01/2021
1Cell Surface ReceptorsIBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1RadiopharmaceuticalsIBA
01/2021
1Proto-Oncogene Proteins c-metIBA
01/2021
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1cabozantinibIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Synaptotagmin IIBA
12/2020
1Purinergic P2X7 ReceptorsIBA
01/2020
16- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA
01/2019
1CannabinoidsIBA
01/2019
1STA 9090IBA
01/2019

Therapy/Procedure

3Therapeutics
03/2023 - 12/2020
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2021
1Drug Therapy (Chemotherapy)
12/2020